NDC 47133-574 Elepsia Xr
Levetiracetam Tablet, Extended Release Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Product Characteristics
BLUE (C48333 - BLUE LAYER)
Code Structure Chart
Product Details
What is NDC 47133-574?
What are the uses for Elepsia Xr?
What are Elepsia Xr Active Ingredients?
- LEVETIRACETAM 1000 mg/1 - A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.
Which are Elepsia Xr UNII Codes?
The UNII codes for the active ingredients in this product are:
- LEVETIRACETAM (UNII: 44YRR34555)
- LEVETIRACETAM (UNII: 44YRR34555) (Active Moiety)
Which are Elepsia Xr Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER (UNII: 905HNO1SIH)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- TALC (UNII: 7SEV7J4R1U)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- CROSPOVIDONE (UNII: 2S7830E561)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- ETHYLCELLULOSE, UNSPECIFIED (UNII: 7Z8S9VYZ4B)
- DIBUTYL SEBACATE (UNII: 4W5IH7FLNY)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
- POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- SHELLAC (UNII: 46N107B71O)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- BUTYL ALCOHOL (UNII: 8PJ61P6TS3)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- AMMONIA (UNII: 5138Q19F1X)
What is the NDC to RxNorm Crosswalk for Elepsia Xr?
- RxCUI: 1605362 - levETIRAcetam 1000 MG 24HR Extended Release Oral Tablet
- RxCUI: 1605362 - 24 HR levetiracetam 1000 MG Extended Release Oral Tablet
- RxCUI: 1605362 - levetiracetam 1000 MG 24 HR Extended Release Oral Tablet
- RxCUI: 1605368 - Elepsia XR 1000 MG 24HR Extended Release Oral Tablet
- RxCUI: 1605368 - 24 HR levetiracetam 1000 MG Extended Release Oral Tablet [Elepsia]
Which are the Pharmacologic Classes for Elepsia Xr?
* Please review the disclaimer below.
Patient Education
Fenofibrate
Fenofibrate is used with a low-fat diet, exercise, and sometimes with other medications to reduce the amounts of fatty substances such as cholesterol and triglycerides in the blood and to increase the amount of HDL (high-density lipoprotein; a type of fatty substance that decreases the risk of heart disease) in the blood. Build-up of cholesterol and fats along the walls of the arteries (a process known as atherosclerosis) decreases the blood flow and, therefore, the oxygen supply to the heart, brain, and other parts of the body. This increases the risk of heart disease, angina (chest pain), strokes, and heart attacks. Although fenofibrate decreases the levels of fatty substances in the blood, it has not been shown to decrease the risk of heart attacks or strokes. Fenofibrate is in a class of medications called antilipemic agents. It works by speeding the natural processes that remove cholesterol from the body.
[Learn More]
Levetiracetam
Levetiracetam is used alone and along with other medications to control partial-onset seizures (seizures that involve only one part of the brain) in adults, children, and infants 1 month of age or older. Levetiracetam is also used in combination with other medications to treat seizure in adults and children 12 years of age or older with juvenile myoclonic epilepsy. Levetiracetam is also used in combination with other medications to treat primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 6 years of age or older with epilepsy. Levetiracetam is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".